Clinical Trial Update: Phase II Study of Regorafenib in Metastatic Soft Tissue Sarcoma [Phase 2]

View source ↗

Summary

Phase II trial of regorafenib in metastatic soft tissue sarcoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• Stivarga (regorafenib)

Snippet

Sponsor: Centre Oscar Lambret | Conditions: Sarcoma | Phase 2 | Status: COMPLETED